Extendicare Inc.
Common Stock · CAD · TSX
Price
C$33.16
Cap
C$2.99B
Earnings
—
30d Trend
+8.3%
26% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 56×Macro 0.99 (−1%)=55
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
12-24 month value thesis — fundamentally underpriced
BRAIN47'S ASSESSMENT
I rate Extendicare Inc. at 55/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 81/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-8.9%
3 MONTHS
-24.2%
12 MONTHS
-25.8%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
12-24 month value thesis — fundamentally underpriced. Fundamentals (81) and Quality (65) are the primary strengths. I note that momentum is the weakest area at 33/100 — this warrants monitoring. Historical volatility is moderate at 26%. I classify this as an income position — the 3.7% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
